Daxor Corp Finalizes $9M Direct Offering at Discounted Price, Signaling Significant Dilution

summarizeSummary

Daxor Corp finalized a $9 million direct offering of common stock at a discounted price of $11.75 per share, leading to significant dilution for existing shareholders and providing capital for general corporate purposes.

check_boxKey Events

• Direct Offering Finalized

  Daxor Corporation finalized a registered direct offering of 765,958 shares of common stock, generating approximately $9,000,006 in gross proceeds. This finalizes terms and pricing of an offering initiated on January 22, 2026.

• Discounted Share Price

  The shares were offered at $11.75 per share, which is a discount compared to the last reported sale price of $13.70 on January 22, 2026, and slightly below today's stock price of $11.79.

• Substantial Dilution

  The offering represents a significant dilution of approximately 15% to existing shareholders, based on the number of shares offered relative to outstanding shares.

• Use of Proceeds

  Net proceeds of approximately $8.14 million will be used for working capital and general corporate purposes, including product development, capital expenditures, and potential investments or debt repayment.

auto_awesomeAnalysis

Daxor Corporation has finalized the terms of a registered direct offering, raising approximately $9 million in gross proceeds. This offering, which follows preliminary prospectus supplements filed on January 22 and 23, 2026, is priced at $11.75 per share, representing a discount to the last reported sale price of $13.70 on January 22, 2026, and slightly below today's market price of $11.79. The capital raise is substantial, representing over 14% of the company's market capitalization and resulting in approximately 15% dilution for existing shareholders. While the proceeds are intended for general corporate purposes, including product development and potential acquisitions, the discounted pricing and significant dilution indicate a pressing need for capital. Investors should also note the company's stated intent to file an application to cease being a registered investment company, which represents a significant strategic shift in its corporate identity and regulatory oversight.